Kinetics of plasma corticosteroids during metyrapone infusion in man. 1979

C LeJeune-Lenain, and R Wolter, and J R Franckson

The effect of metyrapone on plasma kinetics of cortisol (F), 11-deoxycortisol (S), corticosterone (B), 11-deoxycorticosterone (DOC), aldosterone (Aldo) and 17 hydroxyprogesterone (17 OHP) was studied in ten normal prepubertal children intravenously infused with the drug (1 gm/1.73 m2 body surface area in 4 h). Similar falls in F, B and Aldo were observed during the first hour expressing similar sensitivity of the 11 hydroxylases to the drug. The effect of the compensatory increase of endogenous ACTH could be detected after 1 hour by the rise in 17 OHP. However the concentrations of the 11-hydroxy compounds, F, B and Aldo, remained low throughout the infusion period. From the second hour onwards, facilitation of the synthesis of DOC was noticed. After the end of infusion, the levels of the precursors decreased and F and B were restored to initial values. Aldo remained low probably due to the inhibitory effect of the elevated DOC on the renin-angiotensin system.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008797 Metyrapone An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME. Methbipyranone,Methopyrapone,Metopiron,Metopirone,Métopirone,SU 4885
D011282 Pregnenediones Unsaturated pregnane derivatives containing two keto groups on side chains or ring structures. Diketopregnenes,Dioxopregnenes
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D003350 Cortodoxone 17,21-Dihydroxypregn-4-ene-3,20-dione. A 17-hydroxycorticosteroid with glucocorticoid and anti-inflammatory activities. 11-Deoxycortisol,11-Desoxycortisone,Cortexolone,11-Desoxycortisol,Reichstein's Substance S,11 Deoxycortisol,11 Desoxycortisol,11 Desoxycortisone,Reichstein Substance S,Reichsteins Substance S,Substance S, Reichstein's
D003900 Desoxycorticosterone A steroid metabolite that is the 11-deoxy derivative of CORTICOSTERONE and the 21-hydroxy derivative of PROGESTERONE 21-Hydroxyprogesterone,Cortexone,Deoxycorticosterone,Desoxycortone,11-Decorticosterone,21-Hydroxy-4-pregnene-3,20-dione,11 Decorticosterone,21 Hydroxy 4 pregnene 3,20 dione,21 Hydroxyprogesterone
D005260 Female Females

Related Publications

C LeJeune-Lenain, and R Wolter, and J R Franckson
October 1965, Acta medica Scandinavica,
C LeJeune-Lenain, and R Wolter, and J R Franckson
February 1992, Acta physiologica Scandinavica,
C LeJeune-Lenain, and R Wolter, and J R Franckson
December 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
C LeJeune-Lenain, and R Wolter, and J R Franckson
July 1972, The Journal of clinical endocrinology and metabolism,
C LeJeune-Lenain, and R Wolter, and J R Franckson
January 1980, Journal of endocrinological investigation,
C LeJeune-Lenain, and R Wolter, and J R Franckson
July 1989, Journal of applied physiology (Bethesda, Md. : 1985),
C LeJeune-Lenain, and R Wolter, and J R Franckson
December 1975, The Journal of clinical endocrinology and metabolism,
C LeJeune-Lenain, and R Wolter, and J R Franckson
November 1974, Bollettino della Societa italiana di biologia sperimentale,
C LeJeune-Lenain, and R Wolter, and J R Franckson
April 1983, Clinical endocrinology,
C LeJeune-Lenain, and R Wolter, and J R Franckson
March 1991, Clinical science (London, England : 1979),
Copied contents to your clipboard!